MedPath

Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples

Not Applicable
Completed
Conditions
HIV Infections
Sexually Transmitted Disease
Interventions
Behavioral: Eban HIV/STD Risk Reduction Intervention
Behavioral: Eban Health Promotion Intervention
Registration Number
NCT00644163
Lead Sponsor
University of Pennsylvania
Brief Summary

This study will evaluate the effectiveness of a risk-reduction program in preventing the transmission of HIV and sexually transmitted diseases among African-American heterosexual couples, with one partner having been previously diagnosed with an HIV infection.

Detailed Description

The transmission of sexually transmitted diseases (STDs), including HIV, is a major public health concern, especially among minority groups in the United States. Although STDs are prevalent across all racial and ethnic groups in the United States, the rate of STD infection is disproportionately higher for African Americans than for white Americans. African Americans have higher rates of HIV, chlamydia, gonorrhea, syphilis, and herpes than white Americans. An important part of the prevention process is early education on HIV to reduce sexual-risk behavior and to promote safe sexual practices. Interventions are needed in a variety of settings to extensively address African Americans' risk of STDs, including HIV. Although most HIV/STD risk-reduction interventions are conducted at the individual level, a couple-based approach may be more effective and consistent with cultural values. This study will compare the effectiveness of the Eban HIV/STD Risk Reduction Intervention with the Eban Health Promotion Intervention in reducing the risk of STDs among African-American HIV-serodiscordant heterosexual couples.

Participation in this study will last 12 months. All participants will first undergo baseline assessments that will consist of questionnaires and biospecimen collection for STD testing. Participants will then be assigned randomly to one of two treatment groups: the Eban HIV/STD Risk Reduction Intervention group or the Eban Health Promotion Intervention group. Both groups will participate in weekly 2-hour sessions over 8 weeks. The sessions will include couple and group sessions led by trained male and female co-facilitators. The Eban HIV/STD Risk Reduction Intervention sessions will focus on the couple and will teach the couple about communication skills. The approach will draw upon social cognitive theory, an ecological framework, and HIV/STD risk-reduction research with inner-city African-American populations. The Eban Health Promotion Intervention sessions will focus on the individual and will provide factual information on health, screening, exercise, diet management, and medication adherence. Follow-up visits for all participants will occur at Months 3, 6, and 12 and will include repeat baseline assessments.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1070
Inclusion Criteria
  • Each partner agrees that the relationship has lasted at least 6 months before study entry
  • Each partner intends to remain together for at least 12 months after study entry (e.g., state independently that he/she is confident or very confident that they will remain together)
  • At least one partner of the couple reports having unprotected intercourse at least once in the 90 days before study entry
  • Neither partner has plans to relocate beyond a reasonable distance from the study site
  • At least one partner is African American
  • At least one partner agrees that he/she is not planning pregnancy within the next 18 months after study entry
  • Each partner is aware of his/her partner's HIV serostatus
  • Only one partner is HIV seropositive and has known his or her status for at least 3 months before study entry
Exclusion Criteria
  • One or both partners do not have an address where they can receive mail
  • One or both partners have significant psychiatric, physical, or neurological impairment that would limit their effective participation as confirmed on a Mini Mental State Examination and/or Quick Test
  • History of severe physical or sexual abuse in the 1 year before study entry in the current relationship (e.g., significant enough to require medical, psychological, and/or legal intervention)
  • One or both partners are unwilling or unable to commit to participate in the study through to completion
  • Both partners have previously participated in an HIV sexual risk-reduction intervention for couples in the 12 months before study entry
  • One or both partners are not fluent in English as determined by the informed consent process

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Eban HIV/STD Risk Reduction InterventionParticipants will receive Eban HIV/STD Risk Reduction Intervention.
2Eban Health Promotion InterventionParticipants will receive Eban Health Promotion Intervention.
Primary Outcome Measures
NameTimeMethod
Occurrence of STDs (chlamydia, gonorrhea, and trichomonas)Measured at Month 12
Self-reported proportion of condom-protected sexual intercourseMeasured at Month 12
Secondary Outcome Measures
NameTimeMethod
Number of sexual partnersMeasured at Month 12
Unprotected sex occurrenceMeasured at Month 12

Trial Locations

Locations (4)

Emory University

🇺🇸

Atlanta, Georgia, United States

UCLA

🇺🇸

Los Angeles, California, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Columbia University

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath